Evidence map›Paper›PMID 34054372›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2021

May Measurement Month 2019: an analysis of blood pressure screening results from the United Kingdom and Republic of Ireland.

Barry J McDonnell, Emma Rees, John R Cockcroft, Thomas Beaney, Bethan Clayton, Phuong Le Kieu, Adrian J B Brady, Sandosh Padmanabhan, Linsay McCallum, Eamon Dolan and 6 more

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. May Measurement Month 2022: an analysis of blood pressure screening results from the UK and Republic of Ireland.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
  2. May Measurement Month 2021: an analysis of blood pressure screening results from the UK and Republic of Ireland.European heart journal supplements : journal of the European Society of Cardiology · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Barry J McDonnellCardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff CF5 2YB, UK.
Emma ReesFaculty of Health and Life Science, Swansea University, Singleton Campus, Swansea SA2 8PP, UK.
John R CockcroftCardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff CF5 2YB, UK.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Bethan ClaytonUniversity of Manchester, Medical School,Manchester, UK.
Phuong Le KieuUniversity of Manchester, Medical School,Manchester, UK.
Adrian J B BradyUniversity of Glasgow, Glasgow Royal Infirmary, Glasgow G4 0SF, UK.
Sandosh PadmanabhanInstitute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, Glasgow G12 8TD, UK.
Linsay McCallumInstitute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, Glasgow G12 8TD, UK.
Eamon DolanConnolly Hospital Dublin, Dublin, Ireland.
Eoin O'BrienThe Conway Institute, University College Dublin, Dublin, Ireland.
Maciej TomaszewskiUniversity of Manchester, Medical School,Manchester, UK.
Aletta E SchutteFaculty of Medicine, University of New South Wales, George Institute for Global Health, Sydney, Australia.
Neil R PoulterDepartment of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK.
Francesco P CappuccioUniversity of Warwick, Warwick Medical School, and UHCW NHS Trust, Coventry, UK.
International Society of Hypertension and British and Irish Hypertension Society

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the UK, heart and circulatory diseases account for 29% of all deaths (14% through coronary heart disease and 8% through stroke). In 2015, the prevalence of hypertension was 20% in the UK and 23% in the Republic of Ireland. In 2019, 14% of people registered with a UK general practice had hypertension and yet it was the attributable risk factor for around half of all deaths from coronary heart disease or stroke. We participated in May Measurement Month 2019 to increase awareness of blood pressure (BP) measurement, and to identify the proportion of undiagnosed hypertension and degree of uncontrolled hypertension in the community. The 2019 campaign set up screening sites within the community at places of worship, supermarkets, GP surgeries, workplaces, charity events, community pharmacies, gyms, and various other public places. We screened 10194 participants (mean age 51 ± 18 years, 60% women) and found that 1013 (9.9%) were on antihypertensive treatment, while 3408 (33.4%) had hypertension. Of the 3408 participants with hypertension, only 33.5% were aware of their condition despite 98.8% having previous BP measurements. In those on antihypertensive medication, only 38.2% had controlled BP (<140 and <90 mmHg). Our UK and Republic of Ireland data demonstrate concerning levels of undiagnosed hypertension and sub-optimal BP control in many individuals with a diagnosis. This evidence supports a critical need for better systematic community and primary care screening initiatives.

Indexed as

Blood pressureControlHypertensionScreeningTreatment

Identifiers

PMID34054372
PMCPMC8141951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.